Better High-Yield Dividend Stock to Buy: Bristol Myers Squibb or Pfizer?
Source: Motley Fool
2026-06-04 02:50:00 ET
When it comes to pharmaceutical stocks and yield, Bristol Myers Squibb (NYSE: BMY) and Pfizer (NYSE: PFE) stand out. However, when deciding which of the two is the better high-yield dividend stock , you need to consider numerous criteria, not just the raw yield itself.
When it comes to today's yield, Pfizer is the clear victor. However, when considering whether the higher yield is sustainable, factors such as dividend payout ratios and earnings forecasts start to cast doubt.
Pfizer Inc.
NASDAQ: PFE
PFE Trading
1.26% G/L:
$25.765 Last:
14,365,289 Volume:
$25.67 Open:
PFE Latest News
PFE Stock Data
$156,612,814,520
5,628,850,476
0.02%
1712
N/A
Pharmaceuticals
Healthcare
US
New York
